Neurofeedback Removal of Emotional Information From Mind
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Jun 10, 2024
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a technique called neurofeedback, which helps people learn how to control their thoughts by providing real-time feedback about their brain activity. The goal is to see if individuals can be trained to effectively remove unwanted thoughts from their minds. Participants will be shown what it feels like to successfully let go of a thought while they are being monitored using a special brain imaging method called fMRI.
To be eligible for this study, participants should be right-handed, fluent in English, and have at least an 8th-grade education. They should also have good hearing and vision, either naturally or with minimal correction like glasses. However, individuals with certain health issues, such as major psychiatric disorders, neurological or serious medical conditions, or those with metal implants in their body, cannot participate. The trial is not yet recruiting but aims to include people aged 65 to 74 years. Participants will have the opportunity to learn new techniques for managing their thoughts in a supportive environment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Right-handed
- • Speak English fluently
- • Minimum 8th grade education
- • Good hearing
- • Good vision or minimal correction with contacts or eyeglasses
- Exclusion Criteria:
- • History of significant illnesses (including cardiovascular disease, cancer, immunodeficiency disorders (including HIV infection)
- • Diabetes
- • Unstable endocrine disorders
- • Neurological disorders
- • Neuromuscular disorders
- • Blood dyscrasias
- • History of major psychiatric disorders (including schizophrenia, bipolar disorder, and dementia)
- • Substance dependence
- • History of head trauma with loss of consciousness
- • Cerebrovascular accident
- • Seizures
- • Neurosurgical intervention
- • Metal implants in the body (including pacemakers, neurostimulators, or other metal objects)
- • Metal piercings that cannot be removed for the scan
- • Women who are pregnant or who think they may be pregnant
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jarrod Lewis-Peacock, Ph.D.
Principal Investigator
University of Texas at Austin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported